Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanGraft SurvivalAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationCyclophosphamideHematopoietic Stem CellsBusulfanTreatment OutcomeMyeloablative AgonistsMultiple MyelomaStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsRetrospective StudiesVidarabineAmyloidosisHematopoiesisSalvage TherapyLeukemiaSurvival RateIfosfamideSurvival AnalysisVincristineCarmustineBlood CellsGraft vs Leukemia EffectTime FactorsCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountLiver TransplantationMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionFollow-Up StudiesNeoplasmsFatal OutcomeFeasibility StudiesLivedo ReticularisHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsHematologic DiseasesCyclosporineHLA AntigensDoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsBone MarrowImmunosuppressionImmunophenotypingProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellKidney TransplantationPilot ProjectsPrednisoneBone Marrow PurgingCarboplatinBone Marrow DiseasesTransplantation ImmunologyPrognosisAntigens, CDCell TransplantationBlood Group Incompatibility